| ABOUT THE CONFERENCE:
The 7th ESH E-Conference on Myelodysplastic Syndromes (MDS) programme is designed to include leading-edge basic and clinical research. The presentation of unpublished data is encouraged and emphasis is placed on opportunities for the live scientific discussion and interaction we are all missing so cruelly during these challenging times. Prepare your questions and share in the discussions!
The meeting will be of interest to:
– Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
– Junior scientists and clinicians (MD, PhD)
– PhD candidates and clinical residents still in-training
LEARNING OBJECTIVES:
– Learn how to optimally diagnose MDS, by morphological analysis and cytogenetics but also through the use of new tools, mainly for molecular analysis.
– Improve ability to analyze prognostic factors, including new factors (revised IPSS, molecular analysis).
– Review current treatment of MDS in both the high risk and low risk settings, ranging from single follow up to allogeneic stem cell transplantation.
– Acquire improved knowledge of emerging treatments based on targeted therapies and well conducted clinical trials. |
